The medical community is intrigued by retatrutide, a new dual GIP and GLP-1 target that’s showing significant results in clinical research. This medication works by imitating natural hormones to regulate appetite and increase feelings of fullness , ultimately leading considerable weight loss . While currently under review and not yet available, e